论文部分内容阅读
目的探讨在糖尿病患者使用对比剂前后给予风险管理护理的作用及价值。方法将2014年2月至2015年12月接受CT增强的60例糖尿病患者按照随机数字法两分为两组,各30例。对照组给予常规护理,观察组给予风险管理护理,对比两组患者干预前后血肌酐水平。结果干预后,观察组患者血肌酐水平明显低于对照组,差异有统计学意义(P<0.05)。观察组患者无对比剂肾病发生,对照组发生率为13.33%,差异有统计学意义(P<0.05)。结论对CT增强糖尿病患者采用风险管理护理可降低对比剂肾病的发生率。
Objective To explore the role and value of risk management nursing before and after using contrast agent in diabetic patients. Methods 60 patients with diabetes mellitus who underwent CT enhancement from February 2014 to December 2015 were divided into two groups according to random number method, 30 cases in each. The control group was given routine care, and the observation group was given risk management care. The levels of serum creatinine were compared between the two groups before and after intervention. Results After intervention, the serum creatinine level in the observation group was significantly lower than that in the control group (P <0.05). There was no contrast-induced nephropathy in the observation group, with a rate of 13.33% in the control group, with significant difference (P <0.05). Conclusions The risk-management nursing for patients with CT-enhanced diabetes mellitus can reduce the incidence of contrast-induced nephropathy.